Tetra Bio Pharma Inc TBPMQ

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > TBP Hits Major Milestone

<< Previous

Bullboard Posts

Next >>

Comment by Golddetectoron Jan 13, 2022 8:58pm

135 Views

Post# 34315269

RE:TBP Hits Major Milestone

QIXLEEF worth a lot once 1st ever comparison between QIXLEEF and opioid with fda endorsement is published in the next 2 to 3 months. What the drug will worth. Ppl still do not realize the full potential here. QIXLEEF will never reach phase 3. It will be taken by big pharma once results confirm effectiveness for billions.

<< Previous

Bullboard Posts

Next >>

Anaergia expands relationship with PepsiCo